Does PEMBROLIZUMAB Cause Liver function test increased? 206 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 206 reports of Liver function test increased have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.3% of all adverse event reports for PEMBROLIZUMAB.
206
Reports of Liver function test increased with PEMBROLIZUMAB
0.3%
of all PEMBROLIZUMAB reports
24
Deaths
102
Hospitalizations
How Dangerous Is Liver function test increased From PEMBROLIZUMAB?
Of the 206 reports, 24 (11.7%) resulted in death, 102 (49.5%) required hospitalization, and 19 (9.2%) were considered life-threatening.
Is Liver function test increased Listed in the Official Label?
Yes, Liver function test increased is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Liver function test increased?
METHOTREXATE (3,839)
ADALIMUMAB (2,070)
ETANERCEPT (1,829)
LEFLUNOMIDE (1,521)
ABATACEPT (1,415)
TOCILIZUMAB (1,406)
RITUXIMAB (1,325)
SULFASALAZINE (1,263)
HYDROXYCHLOROQUINE (1,259)
TOFACITINIB (1,221)
Which PEMBROLIZUMAB Alternatives Have Lower Liver function test increased Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G